-
Featured
Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults
Researchers at Massachusetts General Hospital recently published the results of their analysis of arrhythmias in the UK Biobank, a national cohort of over 500k community-based individuals recruited to assess risk factors for disorders affecting people from middle-age onward.
-
Featured
Largest genetic study establishes hereditary links to atrial fibrillation
A study led by Mass General cardiologist Patrick T. Ellinor, MD, PhD, identified 97 genetic loci that are significantly associated with atrial fibrillation.
-
Featured
Improved Identification of Patients at Risk for Atrial Fibrillation
Steve Lubitz, MD, MPH, discusses his team’s work focusing on understanding the mechanisms of atrial fibrillation through human genetics, and understanding how best to identify patients at risk for the arrhythmia.
-
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Patrick T. Ellinor, MD, PhD, Steven A. Lubitz, MD, MPH, Thor M. Sundt, MD, and colleagues determined that after cardiac surgery, non–vitamin K antagonist oral anticoagulants are a safe alternative to warfarin for patients with nonvalvular atrial fibrillation who have acceptable bleeding risk.
-
Researchers Develop Detailed Cellular Map of the Heart
A study led by a Massachusetts General Hospital cardiologist used single nucleus sequencing to create a novel, detailed cellular map of the heart.
-
Screening for AFib Using Wearable Activity Trackers and Telehealth
A Massachusetts General Hospital study is testing whether a novel software algorithm can be used to identify atrial fibrillation using wearable devices.
Arrhythmia contributors
-
Conor D. Barrett, MBBCh, BAO
Clinical Director, Cardiac Arrhythmia Service
Recent Article
Treating Athletes with Arrhythmias: A Partnership Approach
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Type 2 Myocardial Infarction Is Prevalent in U.S., Has a Distinct Clinical Profile
-
Patrick T. Ellinor, MD, PhD
Director, Cardiac Arrhythmia Service
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
-
Steven A. Lubitz, MD, MPH
Cardiac Electrophysiologist
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
